pISSN 1226-4512 eISSN 2093-3827

Article

home Article View

Corrigendum

Korean J Physiol Pharmacol 2021; 25(5): 495-495

Published online September 1, 2021 https://doi.org/10.4196/kjpp.2021.25.5.495

Copyright © Korean J Physiol Pharmacol.

Corrigendum to: Protective effects of lutein against vancomycininduced acute renal injury in mice via upregulation of peroxisome proliferator-activated receptor gamma/nuclear factor erythroid 2-related factor 2 and inhibition of nuclear factor-kappaB/caspase 3

Promise M. Emeka1,*, Sahibzada T. Rasool2, Mohamed A. Morsy1,3, Mohamed I. Hairul Islam4, and Muhammad S. Chohan2

Departments of 1Pharmaceutical Sciences and 2Biomedical Sciences, College of Clinical Pharmacy, King Faisal University, Al-Ahsa 31982, Saudi Arabia, 3Department of Pharmacology, Faculty of Medicine, Minia University, El-Minia 61511, Egypt, 4Department of Biological Sciences, College of Science, King Faisal University, Al-Ahsa 31982, Saudi Arabia

Correspondence to:Promise M. Emeka
E-mail: pemeka@kfu.edu.sa

This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License, which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. Copyright © Korean J Physiol Pharmacol, pISSN 1226-4512, eISSN 2093-3827

Corrigendum to:

Korean J Physiol Pharmacol 2021;25(4):321-331.

Published online July 1, 2021. https://doi.org/10.4196/kjpp.2021.25.4.321

The originally published version of this article contained an error in the title. The author apologizes for any inconvenience that it may have caused.

Before correction: Protective effects of lutein against vancomycin-induced acute renal injury in mice via upregulation of peroxisome proliferator-activated receptor gamma/nuclear factor erythroid 2-related factor 2 and inhibition nuclear factor-kappaB/caspase 3

After correction: Protective effects of lutein against vancomycin-induced acute renal injury in mice via upregulation of peroxisome proliferator-activated receptor gamma/nuclear factor erythroid 2-related factor 2 and inhibition of nuclear factor-kappaB/caspase 3